PodParley PodParley
PodParley
NEW DATA EVALUATING THE BOSTON SCIENTIFIC ELUVIA� DRUG-ELUTING VASCULAR STENT SYSTEM DEMONSTRATE 94.4 PERCENT PRIMARY PATENCY RATE AT NINE MONTHS - Hear from Professor Stefan M�ller-H�lsbeck, M.D., PhD, MAJESTIC trial principal investigator episode artwork

EPISODE · Apr 28, 2015

NEW DATA EVALUATING THE BOSTON SCIENTIFIC ELUVIA� DRUG-ELUTING VASCULAR STENT SYSTEM DEMONSTRATE 94.4 PERCENT PRIMARY PATENCY RATE AT NINE MONTHS - Hear from Professor Stefan M�ller-H�lsbeck, M.D., PhD, MAJESTIC trial principal investigator

from MultiVu Healthcare News

Hear from Professor Stefan M�ller-H�lsbeck, M.D., PhD, MAJESTIC trial principal investigator

Episode metadata supplied by the publisher feed · Published Apr 28, 2015

Embed this episode

Ready to play

NEW DATA EVALUATING THE BOSTON SCIENTIFIC ELUVIA� DRUG-ELUTING VASCULAR STENT SYSTEM DEMONSTRATE 94.4 PERCENT PRIMARY PATENCY RATE AT NINE MONTHS - Hear from Professor Stefan M�ller-H�lsbeck, M.D., PhD, MAJESTIC trial principal investigator

0:00 0:00

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

When was this MultiVu Healthcare News episode published?

This episode was published on April 28, 2015.

Can I download this MultiVu Healthcare News episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!